| Application no. and date | 21166753.0 (espacenet) (Federated) (European Patent Register), 20140203 | | Patent/reg. no. and date | DK/EP 3922241, 20231115 | | Publication date | 20211215 | | Priority no. and date | US 201361759914 P, 20130201 | | EP pub. no. and date |
EP 3922241 20211215 | | Effective date | | | Applicant/owner | Celator Pharmaceuticals, Inc., 3170 Porter Drive
Palo Alto, CA 94304, US | | Applicant ref. no. | V2311-021-DK | | Inventor | HAYES, Mark, E,
San Francisco, CA California 94117, US,
NOBLE, Charles, O,
San Francisco, CA California 94107, US,
SZOKA, Francis, C., Jr.,
San Francisco, CA California 94116, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/4196 (2006.01) , A61K 31/496 (2006.01) , A61K 31/5377 (2006.01) , A61K 9/127 (2006.01) , A61K 9/19 (2006.01) | | Title | FJERNLADNING AF SVÆRT VANDOPLØSELIGE LÆGEMIDLER I LIPOSOMER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
